The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes

Louise Buonalumi Tacito Yugar1, Juan Carlos Yugar-Toledo2, Nelson Dinamarco3

  • 1School of Medical Sciences, State University of Campinas (UNICAMP), Campinas 13083-887, SP, Brazil.

Insights

Heart rate variability (HRV) assesses autonomic nervous system function, crucial for understanding hypertension risks. This review explores HRV

Area of Science:

  • Cardiovascular Physiology
  • Autonomic Nervous System
  • Hypertension Research

Background:

  • Autonomic nervous system (ANS) dysfunction, involving the parasympathetic (PNS) and sympathetic (SNS) nervous systems, significantly impacts cardiovascular health.
  • Dysregulation of the ANS contributes to vasomotor impairments, leading to comorbidities like obesity, hypertension (HTN), resistant hypertension, and chronic kidney disease (CKD).
  • Autonomic dysfunction is linked to structural and functional changes in organs, elevating cardiovascular risk.

Purpose of the Study:

  • To evaluate heart rate (HR) as a cardiovascular risk factor in hypertensive patients.
  • To analyze heart rate variability (HRV) as a tool for stratifying risk in various hypertensive states, including pre-hypertension (P-HTN), controlled HTN (C-HTN), resistant HTN (R-HTN), refractory HTN (Rf-HTN), and hypertension with chronic kidney disease (HTN+CKD).

Main Methods:

  • Review of existing literature on cardiac innervation, autonomic nervous system function, and blood pressure regulation.
  • Analysis of heart rate variability (HRV) as a non-invasive method for assessing cardiac autonomic modulation.
  • Exploration of HRV's utility in risk stratification for different hypertensive patient groups.

Main Results:

  • Heart rate (HR) is identified as a significant cardiovascular risk factor in hypertensive individuals.
  • Heart rate variability (HRV) demonstrates potential as a valuable tool for assessing autonomic function and cardiovascular risk.
  • HRV can aid in differentiating risk strata among patients with various forms of hypertension and comorbid conditions like CKD.

Conclusions:

  • Autonomic dysfunction plays a critical role in the pathophysiology and progression of hypertension and its complications.
  • Heart rate variability (HRV) offers a promising, non-invasive approach for clinical evaluation and risk assessment in hypertensive patients.
  • Utilizing HRV can enhance the personalized management of hypertension and associated cardiovascular risks.

Related Concept Videos

Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
3.0K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
2.0K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
29
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K